106 related articles for article (PubMed ID: 18417843)
1. A study of proliferative activity, angiogenesis and nuclear grading in renal cell carcinoma.
Bhattacharyya NK; Chatterjee U; Sarkar S; Kundu AK
Indian J Pathol Microbiol; 2008; 51(1):17-21. PubMed ID: 18417843
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma.
El-kott AF; El-baz MA; Mokhtar AA
Int Urol Nephrol; 2006; 38(2):237-42. PubMed ID: 16868689
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7.
Amare Kadam PS; Varghese C; Bharde SH; Narasimhamoorthy NK; Desai S; Advani SH; Havaldar R; Kulkarni JN
Cancer Genet Cytogenet; 2001 Mar; 125(2):139-46. PubMed ID: 11369057
[TBL] [Abstract][Full Text] [Related]
4. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between tumor angiogenesis and cellular proliferation activity in nasal inverted papilloma].
Zhao W; Zhang D; Zhang H; Dong Ye S
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Aug; 18(8):460-2. PubMed ID: 15571308
[TBL] [Abstract][Full Text] [Related]
6. [Significance of proliferating cell nuclear antigen (PCNA) index and microvessel density (MVD) in endometrial carcinoma].
Xiao L; Tang LD
Ai Zheng; 2005 Jan; 24(1):19-22. PubMed ID: 15642194
[TBL] [Abstract][Full Text] [Related]
7. Morphometric study of nuclei and microvessels in gliomas and its correlation with grades.
Boruah D; Deb P; Srinivas V; Mani NS
Microvasc Res; 2014 May; 93():52-61. PubMed ID: 24657905
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
9. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
[TBL] [Abstract][Full Text] [Related]
10. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
Delahunt B; Bethwaite PB; Thornton A; Ribas JL
Cancer; 1995 Jun; 75(11):2714-9. PubMed ID: 7743475
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma.
Morell-Quadreny L; Clar-Blanch F; Fenollosa-Enterna B; Perez-Bacete M; Martinez-Lorente A; Llombart-Bosch A
Anticancer Res; 1998; 18(1B):677-82. PubMed ID: 9584051
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of flow-cytometry and immunohistochemistry with proliferating monoclonal antibody. Cell nuclear antigen (PCNA) in the study of proliferative kinetics of renal carcinoma].
Villari D; Iannelli F; Li Marzi V; Marzocco M; Amorosi A; Trippitelli A; Nicita G
Arch Ital Urol Androl; 1997 Feb; 69 Suppl 1():33-7. PubMed ID: 9181920
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in renal cell carcinoma: correlation of microvessel density and microvessel area with other prognostic factors.
Sharma SG; Aggarwal N; Gupta SD; Singh MK; Gupta R; Dinda AK
Int Urol Nephrol; 2011 Mar; 43(1):125-9. PubMed ID: 20535637
[TBL] [Abstract][Full Text] [Related]
15. Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior.
Lee JS; Kim HS; Jung JJ; Kim YB; Park CS; Lee MC
Anal Quant Cytol Histol; 2001 Apr; 23(2):161-8. PubMed ID: 11332083
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma.
Rioux-Leclercq N; Epstein JI; Bansard JY; Turlin B; Patard JJ; Manunta A; Chan T; Ramee MP; Lobel B; Moulinoux JP
Hum Pathol; 2001 Nov; 32(11):1209-15. PubMed ID: 11727260
[TBL] [Abstract][Full Text] [Related]
17. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
Larsson P; Roos G; Stenling R; Ljungberg B
Scand J Urol Nephrol; 1996 Dec; 30(6):445-50. PubMed ID: 9008023
[TBL] [Abstract][Full Text] [Related]
20. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]